Division of Urology, O.L.V. Vattikuti Robotic Surgery Institute, Aalst, Belgium; Division of Urology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.
BJU Int. 2014 Dec;114(6):903-9. doi: 10.1111/bju.12751. Epub 2014 Aug 11.
To evaluate the perioperative, postoperative and functional outcomes of robot-assisted partial nephrectomy (RAPN) for renal tumours with high surgical complexity at a large volume centre.
Perioperative and functional outcomes of RAPNs for renal tumours with a Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) score of ≥10 performed at our institution between September 2006 and December 2012 were collected in a prospectively maintained database and analysed. Surgical complications were graded according to the Clavien-Dindo classification. Serum creatinine and estimated glomerular filtration rate (eGFR) were assessed at the third postoperative day and 3-6 months after RAPN.
In all, 44 RAPNs for renal tumours with PADUA scores of ≥10 were included in the analysis; 23 tumours (52.3%) were cT1b. The median (interquartile range; range) operative time, estimated blood loss and warm ischaemia time (WIT) were 120 (94, 132; 60-230) min, 150 (80, 200; 25-1200) mL and 16 (13.8, 18; 5-35) min, respectively. Two intraoperative complications occurred (4.5%): one inferior vena caval injury and one bleed from the renal bed, which were both managed robotically. There were postoperative complications in 10 patients (22.7%), of whom four (9.1%) were high Clavien grade, including two bleeds that required percutaneous embolisation, one urinoma that resolved with ureteric stenting and one bowel occlusion managed with laparoscopic adhesiolysis. Two patients (4.5%) had positive surgical margins (PSMs) and were followed expectantly with no radiological recurrence at a mean follow-up of 23 months. The mean serum creatinine levels were significantly increased after surgery (121.1 vs 89.3 μmol/L; P = 0.001), but decreased over time, with no significant differences from the preoperative values at the 6-month follow-up (96.4 vs 89.3 μmol/L; P = 0.09). The same trend was seen for eGFR.
In experienced hands RAPN for renal tumours with a PADUA score of ≥10 is feasible with short WIT, acceptable major complication rate and good long-term renal functional outcomes. A slightly higher risk of PSMs can be expected due to the high surgical complexity of these lesions. The robotic technology allows a safe expansion of the indications of minimally invasive PN to anatomically very challenging renal lesions in referral centres.
在一个大样本量中心,评估高手术复杂度的肾肿瘤患者行机器人辅助部分肾切除术(RAPN)的围手术期、术后和功能结果。
2006 年 9 月至 2012 年 12 月期间,在我们的机构中,对术前方面和用于解剖的维度(PADUA)评分≥10 的肾肿瘤患者进行了前瞻性维护数据库中收集 RAPN 的围手术期和功能结果,并进行了分析。手术并发症根据 Clavien-Dindo 分类进行分级。RAPN 术后第 3 天和 3-6 个月时评估血清肌酐和估算肾小球滤过率(eGFR)。
共纳入 44 例 PADUA 评分≥10 的肾肿瘤行 RAPN 分析;23 例肿瘤(52.3%)为 cT1b。中位(四分位距;范围)手术时间、估计失血量和热缺血时间(WIT)分别为 120(94,132;60-230)min、150(80,200;25-1200)mL 和 16(13.8,18;5-35)min。术中发生 2 例并发症(4.5%):下腔静脉损伤 1 例,肾床出血 1 例,均经机器人处理。10 例(22.7%)患者术后发生并发症,其中 4 例(9.1%)为高 Clavien 分级,包括 2 例需要经皮栓塞的出血、1 例需要输尿管支架置入的尿囊肿和 1 例需要腹腔镜粘连松解的肠闭塞。2 例(4.5%)患者有阳性切缘(PSM),随访时未发现影像学复发,平均随访 23 个月。术后血清肌酐水平明显升高(121.1 与 89.3μmol/L;P=0.001),但随时间推移逐渐下降,6 个月随访时与术前值无显著差异(96.4 与 89.3μmol/L;P=0.09)。eGFR 也有同样的趋势。
在经验丰富的手中,对于 PADUA 评分≥10 的肾肿瘤患者,RAPN 可行,WIT 短,主要并发症发生率可接受,长期肾功能结果良好。由于这些病变的手术复杂性较高,预计 PSM 的风险略高。机器人技术允许在转诊中心安全地扩大微创 PN 的适应证,用于解剖上极具挑战性的肾病变。